Development

A one-time CAR-T therapy controls HIV in a first-in-human trial

development2026-05-17

Claim

In a first-in-human trial, the nonprofit Caring Cross re-engineered an HIV patient's own T-cells to hunt the virus at its binding sites, controlling the infection with a single one-time therapy.

Reporting date: 2026-05-17 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to May 17, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to May 17, 2026

Actor

Caring Cross

Evidence for

Biology engineered past the constraints of life

Supersedes

Nearly five thousand new drug trials begin, half of them in China

Referenced by

Cite or correct this record

Citation formatCitation text

A one-time CAR-T therapy controls HIV in a first-in-human trial
Innermost Loop KB — secondary record
Reporting date: 2026-05-17
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-05-17-one-time-car-t-controls-hiv
Claim: In a first-in-human trial, the nonprofit Caring Cross re-engineered an HIV patient's own T-cells to hunt the virus at its binding sites, controlling the infection with a single one-time therapy.
Attributed sources:
- Welcome to May 17, 2026 — https://theinnermostloop.substack.com/p/welcome-to-may-17-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.